stockmarketnews.online EDGAR snapshot
The Filings Docket Corporate filings, explained: what large U.S. companies filed with the SEC, and what it means.

In re: AMGEN INC · CIK 0000318154

When will Amgen Inc. file its next 10-Q?

AMGN · Nasdaq
Snapshot

Amgen Inc. is expected to file its next quarterly report (Form 10-Q), for the period ending about Sept. 30, 2026, between Nov. 2, 2026 and Nov. 9, 2026, based on its last 8 10-Q filings. The SEC deadline for a large accelerated filer is Nov. 9, 2026.

How the next-report window is calculated

Amgen Inc.'s most recent periodic report on file is a Form 10-Q for the period ended June 30, 2026, filed Aug. 5, 2026. Its fiscal year ends around Dec. 31, so the next period should close about Sept. 30, 2026, and that report is a Form 10-Q.

SEC rules give a large accelerated filer 40 days after period end to file a 10-Q, which lands on Nov. 9, 2026 after moving off weekends and federal holidays. Over its last 8 10-Qs, Amgen Inc. filed between 31 and 38 days after period end (median 35 days), which gives the expected window above. Period ends are estimated from the company's own calendar and may shift by a few days in 52/53-week fiscal years.

Amgen Inc.: days from period end to 10-Q/10-K filing 10-Q for period ended 2024-09-30: filed 31 days later; 10-K for period ended 2024-12-31: filed 45 days later; 10-Q for period ended 2025-03-31: filed 32 days later; 10-Q for period ended 2025-06-30: filed 37 days later; 10-Q for period ended 2025-09-30: filed 36 days later; 10-K for period ended 2025-12-31: filed 44 days later; 10-Q for period ended 2026-03-31: filed 31 days later; 10-Q for period ended 2026-06-30: filed 36 days later. 10-Q due: 40d 10-K due: 60d 10-Q · Sept. 30 24 31d 10-K · Dec. 31 24 45d 10-Q · March 31 25 32d 10-Q · June 30 25 37d 10-Q · Sept. 30 25 36d 10-K · Dec. 31 25 44d 10-Q · March 31 26 31d 10-Q · June 30 26 36d days from period end to filing date →

Recent filings by Amgen Inc.

Most recent 25 filings excluding insider Forms 3/4/5/144 · SEC EDGAR, retrieved Oct. 16, 2026
FiledFormWhat it isDocument
10-Q Quarterly report with unaudited financial statements for the period ended June 30, 2026 Open 10-Q filed 2026-08-05 · Index 0000318154-26-000126
8-K Released earnings or financial results Open 8-K filed 2026-08-04 · Index 0000318154-26-000124
8-K Material cybersecurity incident Open 8-K filed 2026-07-31 · Index 0000318154-26-000119
11-K Annual report of an employee stock purchase or savings plan Open 11-K filed 2026-06-11 · Index 0000318154-26-000114
11-K Annual report of an employee stock purchase or savings plan Open 11-K filed 2026-06-11 · Index 0000318154-26-000113
8-K Reported shareholder vote results Open 8-K filed 2026-05-20 · Index 0001193125-26-232786
8-K Executive or board change, or executive pay arrangement Open 8-K filed 2026-05-19 · Index 0000318154-26-000097
13G Ownership above 5% by a passive or institutional investor Open SCHEDULE 13G filed 2026-05-14 · Index 0001422849-26-000085
10-Q Quarterly report with unaudited financial statements for the period ended March 31, 2026 Open 10-Q filed 2026-05-01 · Index 0000318154-26-000057
8-K Released earnings or financial results Open 8-K filed 2026-04-30 · Index 0000318154-26-000054
13G Ownership above 5% by a passive or institutional investor Open SCHEDULE 13G filed 2026-04-29 · Index 0002100119-26-000132
8-K Executive or board change, or executive pay arrangement Open 8-K filed 2026-04-22 · Index 0000318154-26-000048
DEFA14A Additional proxy soliciting materials Open DEFA14A filed 2026-04-21 · Index 0000318154-26-000045
DEFA14A Additional proxy soliciting materials Open DEFA14A filed 2026-04-15 · Index 0000318154-26-000040
DEFA14A Additional proxy soliciting materials Open DEFA14A filed 2026-04-07 · Index 0001193125-26-145596
DEF 14A Definitive proxy statement for a shareholder meeting Open DEF 14A filed 2026-04-07 · Index 0001193125-26-145588
ARS Annual report delivered to shareholders Open ARS filed 2026-03-31 · Index 0000318154-26-000035
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2026-03-26 · Index 0000102909-26-000625
25-NSE Exchange notice removing a security from listing Open 25-NSE filed 2026-02-24 · Index 0001354457-26-000212
8-K Signed a material contract Open 8-K filed 2026-02-19 · Index 0001193125-26-059490
S-3ASR Automatic shelf registration (well-known seasoned issuer) Open S-3ASR filed 2026-02-13 · Index 0001193125-26-051627
10-K Annual report with audited financial statements for the period ended Dec. 31, 2025 Open 10-K filed 2026-02-13 · Index 0000318154-26-000010
8-K Released earnings or financial results Open 8-K filed 2026-02-03 · Index 0000318154-26-000003
8-K Ended a material contract Open 8-K filed 2026-01-30 · Index 0001193125-26-030518
10-Q Quarterly report with unaudited financial statements for the period ended Sept. 30, 2025 Open 10-Q filed 2025-11-05 · Index 0000318154-25-000072

What Amgen Inc.'s 8-Ks were about in the past year

Amgen Inc. filed 10 Form 8-K current reports between Oct. 17, 2025 and Oct. 16, 2026. Each report lists the item numbers it covers; the counts below show how often each item appeared.

ItemMeaningTimes
9.01Financial Statements and Exhibits7
2.02Results of Operations and Financial Condition4
5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers2
1.05Material Cybersecurity Incidents1
5.07Submission of Matters to a Vote of Security Holders1
1.01Entry into a Material Definitive Agreement1
1.02Termination of a Material Definitive Agreement1

See what each 8-K item means.